Business South Korean regulator approves GC Biopharma’s COVID-19 mRNA vaccine trial Last updated: December 23, 2025 4:22 am Editor Published: December 23, 2025 Share South Korean regulator approves GC Biopharma’s COVID-19 mRNA vaccine trial WATCH: Ras Al Khaimah units World Report with firework and drone show to welcome 2026 US intelligence signifies Putin’s struggle goals in Ukraine are unchanged Earnings name transcript: Shinhan Monetary Group beats Q1 2026 forecasts High 5 finest builders communities to comply with in 2022 Export controls on Anthropic stem from firm’s ‘recklessness,’ official says Sign Up For Daily NewsletterBe keep up! Get the latest breaking news delivered straight to your inbox.[mc4wp_form]By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. Share This Article Facebook Email Copy Link Print Previous Article Uncommon Bullish Patterns Align With Highly effective Catalysts Next Article dont use 221225 – FX Markets Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Follow USFind US on Socials FacebookLikeXFollowYoutubeSubscribeTelegramFollow Popular News Cerebras Inventory Falls Beneath $185 IPO Value Amid GPT-6.1 Nvidia-GPU Declare June 2026 Work Progress: New Pearl Pool, Zcash Hardfork, and Two Delistings OpenSea to Assist Arc From Day One among Mainnet Launch
